Mithra Launches Capital Increase By Means of a Private Placement via an Accelerated Bookbuild Offering and Provides an Update on its Financing Strategy

  • Launch of a capital increase of approximately EUR 55 million by means of a private placement via an accelerated bookbuild offering
  • Loan of EUR 20 million secured, in addition to the recent capital commitment agreement with LDA for up to EUR 50 million
  • Last building blocks in the Company’s financing strategy in becoming a commercial company

Liège, Belgium, 18 June 2020, 14:30 CEST – Mithra Pharmaceuticals SA (the “Company” or “Mithra”), a company specialized in Women’s Health (Euronext Brussels: MITRA), announces today the launch of a capital increase of approximately EUR 55 million by means of a private placement via an accelerated bookbuild offering (the “Private Placement”).